S. Kodama et al., Carcinoembryonic antigen and carbohydrate antigen 19-9-producing adenocarcinoma of the prostate: Report of an autopsy case, UROL INTERN, 63(3), 1999, pp. 193-197
Prostate-specific antigen (PSA) and prostatic acid phosphatase (PAP) are we
ll known as specific tumor markers of prostate cancer, but carcinoembryonic
antigen (CEA)and carbohydrate antigen 19-9 (CA19-9)-producing adenocarcino
ma originating in the prostate is rare. We report here a case of prostatic
adenocarcinoma positive for these 4 tumor markers in a 50-year-old man who
had initially complained about chest pain due to metastatic bone tumor. In
spite of the extensive treatment involving hormone and radiation therapy, t
he patient died of rapid tumor extension only 4 months after initial diagno
sis, Autopsy revealed multiple metastases to the bone, liver, lungs and lym
ph nodes. Histologically, two types of adenocarcinoma were involved in both
primary prostate and metastatic sites: one was a poorly differentiated ade
nocarcinoma positive for PSA and PAP but not CEA or CA19-9, and the other o
ne was a less differentiated adenocarcinoma partially positive for CEA and
CA19-9 but not for PSA or PAP. Based on this case and previous cases by rev
iew of the literature, CEA- and CA19-9-producing adenocarcinoma of the pros
tate was suggested to rapidly progress with multiple metastases and to show
poor prognosis with strong resistance to any treatment, Copyright (C) 2000
S. Karger AG, Basel.